Chapter 18 - THE PATENT THAT BELONGED TO NO CHILDThe medical patent was called V7 Regenerative Response.
Adrian chose the name before Protocol Seven existed publicly.
The number did not honor Cassidy.
It marked the seventh blood sample collected from Celia during infancy.
Sample V7 produced the strongest response in laboratory tissue.
Researchers filed the original patent through a defense contractor. Vale Dominion later acquired the commercial rights through Adrian’s Black Key companies.
Eleanor created Silver Rose after learning that physicians had drawn blood from Celia during procedures she had not fully understood or approved.
She did not free Celia from the program.
She demanded control of it.
Each parent believed the other was the greater danger.
Neither returned authority to the child.
An independent medical panel reviewed the science.
The marker itself could not be owned.
A person’s naturally occurring genetic sequence was not a family asset.
Specific treatment processes could be patented if developed lawfully, but several V7 methods relied on samples obtained without adequate consent.
Those claims faced invalidation.
Existing patients would not lose treatment overnight. Hospitals could continue medically necessary care while public laboratories recreated lawful versions without requiring new blood from Grace, Cassidy, or Celia.
The patent’s value fell immediately.
Adrian called the ruling catastrophic.
Cassidy called it accurate.
Then Evelyn found the spouse-selection file.
Brendan had not been chosen only because he was emotionally insecure and financially vulnerable.
His family carried a common genetic variant that, when combined with the Vale line, increased the likelihood of active V7 expression in a child.
The chance remained uncertain.
Eleanor’s network had arranged the museum fundraiser after medical consultants identified several socially accessible men with the variant.
Brendan ranked highest because the Morrisons needed money.
Cassidy read the file in silence.
Her parents had not merely selected a husband likely to betray her.
They had selected a potential father.
Adrian financed Morrison Urban Development’s rescue through hidden Vale companies. Diane believed the support came from investors impressed by Brendan.
Eleanor’s agents arranged repeated meetings.
Serena observed the relationship.
Arthur received no genetic explanation, but he approved financial access because Adrian’s old instructions described Brendan as strategically useful.
Brendan learned part of the truth six months after the wedding.
Diane found a Black Key payment labeled compatibility retention and demanded answers from Adrian’s intermediary.
The intermediary explained that a future child might unlock medical intellectual property worth more than Morrison Urban Development.
Brendan did not tell Cassidy.
He continued fertility and prenatal testing.
During questioning, he admitted seeing the word V7 before the pregnancy.
“I thought it referred to a trust class.”
“You knew our child had value beyond company shares,” Cassidy said through the recorded interview.
“I knew there might be medical rights.”
“Did you know my parents selected you?”
“No.”
“Did you ask why they cared about your blood tests?”
“My mother said powerful families investigate everyone.”
“And that satisfied you?”
“It benefited us.”
The answer remained Brendan’s most consistent truth.
When silence benefited him, he treated uncertainty as permission.
Cassidy authorized independent paternity testing after Grace stabilized.
Brendan was the biological father.
No hidden donor.
No substituted sample.
The result changed medical history.
It did not restore parental authority.
Brendan requested to visit the NICU.
Family court denied immediate access because he had participated in plans to induce labor, restrict Cassidy’s contact, and transport the baby.
A photograph was not automatically owed to him.
His attorney argued attachment should begin early.
Grace’s advocate answered:
“Attachment is not a right created by genetic contribution while safety findings remain unresolved.”
Cassidy did not ask the court to falsify the birth record.
Grace would later know who her biological father was and what he had done.
Protection did not require replacing truth with a cleaner story.
Adrian attempted one final argument.
“If V7 enters public research, foreign companies will profit from what our family preserved.”
Cassidy looked toward him.
“Celia’s blood preserved it. Patients risked their bodies. Scientists did the work. Employees built the company. Stop calling everything the family’s.”
Eleanor’s maternal veto remained active because it had been tied to the belief that a female heir must control any medical use involving descendants.
Evelyn proposed transferring the veto into an independent patient-consent authority.
Eleanor refused.
“Without a Vale woman holding the key, men will repeat what happened to Celia.”
Celia appeared on the secure screen.
“A Vale woman held the key while it happened to me.”
Eleanor closed her eyes.
For the first time, both daughters stood against her in the same proceeding.
Not as allies created by blood.
As two adults rejecting the role assigned to them.
Eleanor requested twenty-four hours before deciding.
Cassidy refused to let the company remain frozen around her mother’s emotions.
The court suspended the veto temporarily.
Protocol Seven reached one hundred percent.
Then another safeguard activated.
FOUNDER TRANSFER REQUIRES DISCLOSURE OF ALL MINOR SUBJECTS.
The V7 archive contained nineteen children whose samples had been collected through Silver Rose shelters.
Eleanor had known about twelve.
May you like
Adrian had known about all nineteen.
👉 The patent lost its claim over Grace and Celia, but dissolving the founders’ control exposed nineteen children whose bodies had already been used to keep V7 alive.
